Federal Circuit Dismisses WeatherTech Rehearing Petition, Upholding Patent Invalidations

The Federal Circuit has dismissed a petition for rehearing in the case involving WeatherTech. The court had previously invalidated two patents linked to the WeatherTech brand of floor mat. Interestingly, these patents were originally upheld at the Patent Trial and Appeal Board. The dismissal means that the Federal Circuit’s previous decision to invalidate these patents…

Read More

Intuitive Surgical and Auris Settle High-Stakes Robotic Surgery Patent Dispute

In a long-winded patent battle among industry giants Intuitive Surgical and Johnson & Johnson subsidiary Auris, there has finally been a resolution. The two entities have agreed to settle a nearly five-year lawsuit regarding accusations of infringement on various surgical robot patents. The agreement thereby concludes a span of protracted litigation that began back in…

Read More

Navigating Legal Complexities: In-House Counsel’s Guide to AI and Intellectual Property

Generative Artificial Intelligence (AI) platforms and large language models are transforming organizations, altering traditional work norms and increasing productivity. Yet, they also bring complex legal ramifications, challenging in-house counsel to navigate this novel landscape. This issue is particularly significant for firms with an enhanced need to shield their Intellectual Property. This precis aims to underline…

Read More

Navigating Intellectual Property Risks in the Age of Generative AI

The advent of readily accessible artificial intelligence (AI), and particularly generative AI (GAI), has transformed key aspects of business operations ranging from crafting slogans to creating music and art. Alone, these uses represent an exciting frontier in technological capability, but practitioners must be mindful of considerable, still-evolving, legal risks. Specifically, businesses employing GAI for public-facing…

Read More

Meta Settles AI Startup’s Stolen Code Suit, Addressing Intellectual Property Ethics

Meta Platforms Inc. and a Boston-based artificial intelligence company have reached an agreement, settling a suit alleging intellectual property theft by Meta from the startup. The parties informed a Massachusetts federal judge of their settlement on Tuesday, just a month before the trial was scheduled to commence. The suit accused Meta of unscrupulous tactics, alleging…

Read More

Supreme Court Ruling Puzzles Industry: The Impact on Global Trademark Enforcement

The landscape of foreign trademark infringement has experienced a significant shake following the U.S. Supreme Court’s end-of-term decision in Abitron v. Hetronic. It has presented new challenges for brand owners and courts who are struggling to understand the implications of the ruling and how it affects the application of the federal Lanham Act in global…

Read More

PTAB Denies Mercedes Benz USA’s Institution Petition in High-Stakes Patent Dispute with Westport Fuel Systems

In a noteworthy instance of patent law, the Patent Trial and Appeal Board (PTAB) has denied an institution petition from Mercedes Benz USA, disputing the filing date of a challenged patent held by Westport Fuel Systems Canada Inc. The case in question, Mercedes-Benz USA, LLC v. Westport Fuel Systems Canada Inc, Case IPR2023-00351, unfolded earlier…

Read More

Gizmodo Editor-in-Chief Accuses Apple of Plagiarizing “The Tetris Effect” in Film Adaptation

The editor-in-chief of technology news website Gizmodo has entered a legal dispute with tech giant Apple Inc., accusing the company of plagiarising his 2016 published book, “The Tetris Effect”, in their latest release, a film titled “Tetris.” In a statement, the Gizmodo chief editor claimed that the Apple-produced film is “substantially similar in almost all…

Read More

Duane Morris LLP Enhances West Coast Litigation Capability with Seasoned White-Collar and IP Attorney

In continuing with their expansion plans on the West Coast, Duane Morris LLP recently announced a new addition to their team. They are adding a seasoned white-collar lawyer and Intellectual Property (IP) attorney to their San Francisco team, reinforcing their litigation capability in the region. The attorney, formerly associated with DLA Piper, is set to…

Read More

SEC Mandates Prompt Cybersecurity Incident Disclosure for Public Companies

The US Securities and Exchange Commission (SEC) has recently adopted new regulations mandating public companies to disclose substantial cybersecurity incidents on Form 8-K within four working days of ascertaining the materiality of such an event. The jurisdiction of the SEC also demands companies to elaborate routinely on their methods for assessing, pinpointing, and managing significant…

Read More

Federal Circuit Panel Recommends Controversial Suspension of Intellectual Property Judge Pauline Newman

Pauline Newman, a highly respected name in intellectual property law, has found herself under scrutiny from colleagues and subjected to a ruling by a Federal Circuit panel recommending a year-long suspension from judging. The crux of their claim lies in questioning her mental and physical health. The panel has pointed to supposed deficiencies in Newman’s…

Read More

Navigating Due Diligence in Pharmaceutical CRO Acquisitions: Key Challenges and Opportunities

In the highly competitive pharmaceutical services sector, avid bidding for prominent businesses have observed an exponential acceleration as new players and investors are showing everyday interest. This surge in investors, who previously didn’t focus much on the pharma sector, has necessitated an urgent understanding of central considerations for due diligence. These considerations significantly influence risk…

Read More

Acorda Therapeutics Secures $16.6M Win in NY Federal Court Over MS Drug Dispute

In accord with a recent ruling, a New York federal judge throws his support to a near $16.6 million arbitrated award issued to Acorda Therapeutics Inc. Acorda Therapeutics, the American biotechnology company based in Ardsley, New York, has been in dispute with Ireland’s global biopharmaceutical company, Alkermes PLC, consequent to a bone of contention revolving…

Read More